Filed: 5/14/2024ACC: 0001999371-24-006067
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 89 equity positions with a total reported market value of $807.77M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
89
Positions
$807.77M
Total AUM (reported)
97.26M
Total Shares
Allocation by class
COM$458.32M56.7%
SPONSORED ADS$74.20M9.2%
S&P BIOTECH$66.42M8.2%
COM NEW$47.37M5.9%
CL A$21.77M2.7%
SPON ADS$21.53M2.7%
COMMON STOCK$20.86M2.6%
Portfolio Concentration
Top 3$152.15M18.8%
4–10$191.91M23.8%
11–25$209.35M25.9%
Rest$254.36M31.5%
Top 3 weight
18.8%
Top 10 weight
42.6%
Voting Authority Distribution
Total shares with voting rights: 96.99M
Sole
Full voting authority
96.99M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole89
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings89
Rows:
SPDR SER TR
SOLEShares700K
TypeSH
Market value$66.42M
8.22%
Sole
700K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares3.06M
TypeSH
Market value$43.11M
5.34%
Sole
3.06M
Shared
0.00
None
0.00
MODERNA INC
SOLEShares400K
TypeSH
Market value$42.62M
5.28%
Sole
400K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares592.09K
TypeSH
Market value$39.34M
4.87%
Sole
592.09K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares837.39K
TypeSH
Market value$36.05M
4.46%
Sole
837.39K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares115K
TypeSH
Market value$30.71M
3.80%
Sole
115K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares470K
TypeSH
Market value$22.00M
2.72%
Sole
470K
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares3.38M
TypeSH
Market value$21.53M
2.67%
Sole
3.38M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares510K
TypeSH
Market value$21.40M
2.65%
Sole
510K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares300K
TypeSH
Market value$20.86M
2.58%
Sole
300K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares470K
TypeSH
Market value$20.27M
2.51%
Sole
470K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares2.64M
TypeSH
Market value$20.24M
2.51%
Sole
2.64M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares17M
TypePRN
Market value$18.30M
2.27%
Sole
17M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares730.49K
TypeSH
Market value$15.58M
1.93%
Sole
730.49K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares410K
TypeSH
Market value$15.55M
1.93%
Sole
410K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares429.40K
TypeSH
Market value$13.87M
1.72%
Sole
429.40K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares817.83K
TypeSH
Market value$13.16M
1.63%
Sole
817.83K
Shared
0.00
None
0.00
BEIGENE LTD
SOLEShares82.14K
TypeSH
Market value$12.85M
1.59%
Sole
82.14K
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares300K
TypeSH
Market value$12.68M
1.57%
Sole
300K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares810.25K
TypeSH
Market value$11.91M
1.47%
Sole
810.25K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares845.61K
TypeSH
Market value$11.90M
1.47%
Sole
845.61K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares150K
TypeSH
Market value$11.26M
1.39%
Sole
150K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares139.76K
TypeSH
Market value$11.15M
1.38%
Sole
139.76K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares214.59K
TypeSH
Market value$10.92M
1.35%
Sole
214.59K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares165K
TypeSH
Market value$9.70M
1.20%
Sole
165K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 700K | SH | $66.42M 8.22% | 700K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 3.06M | SH | $43.11M 5.34% | 3.06M | 0.00 | 0.00 |
MODERNA INCSOLE | COM | 400K | SH | $42.62M 5.28% | 400K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 592.09K | SH | $39.34M 4.87% | 592.09K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 837.39K | SH | $36.05M 4.46% | 837.39K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 115K | SH | $30.71M 3.80% | 115K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 470K | SH | $22.00M 2.72% | 470K | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 3.38M | SH | $21.53M 2.67% | 3.38M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 510K | SH | $21.40M 2.65% | 510K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 300K | SH | $20.86M 2.58% | 300K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 470K | SH | $20.27M 2.51% | 470K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 2.64M | SH | $20.24M 2.51% | 2.64M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 17M | PRN | $18.30M 2.27% | 17M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 730.49K | SH | $15.58M 1.93% | 730.49K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 410K | SH | $15.55M 1.93% | 410K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 429.40K | SH | $13.87M 1.72% | 429.40K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 817.83K | SH | $13.16M 1.63% | 817.83K | 0.00 | 0.00 |
BEIGENE LTDSOLE | SPONSORED ADR | 82.14K | SH | $12.85M 1.59% | 82.14K | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 300K | SH | $12.68M 1.57% | 300K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 810.25K | SH | $11.91M 1.47% | 810.25K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 845.61K | SH | $11.90M 1.47% | 845.61K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 150K | SH | $11.26M 1.39% | 150K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 139.76K | SH | $11.15M 1.38% | 139.76K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 214.59K | SH | $10.92M 1.35% | 214.59K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 165K | SH | $9.70M 1.20% | 165K | 0.00 | 0.00 |
Page 1 of 4